Oluwaseyi Sedowhe Ashaka

Dr. Oluwaseyi Sedowhe Ashaka

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
OAOluwaseyi Sedowhe Ashaka
Oluwaseyi Sedowhe Ashaka
AOAdesuyi Ayodeji Omoare
Adesuyi Ayodeji Omoare
AJAyorinde James
Ayorinde James
OAOluwapelumi Olufemi Adeyemi
Oluwapelumi Olufemi Adeyemi
FOFemi Oladiji
Femi Oladiji
OAOlajide Olubunmi Agbede
Olajide Olubunmi Agbede
Regional variations exist in HPV prevalence worldwide despite reports of high prevalence rates among African women. Limited data on genital HPV prevalence necessitated this study with the aim of determining the prevalence of genital HPV and associated risk factors among women in Lagos, Nigeria. Exfoliated cervical cells were collected with consent from 165 women using a cervical brush. Viral DNA was extracted and amplified by nested PCR using two sets of consensus primers (MY09/11 and GP5+/6+). An unconditional logistic regression model was used to identify predictors of HPV positivity. The HPV prevalence was 81.82% in all women and 87.59% in women with normal cytology. The risk of HPV infection was significantly increased among women who had a history of STI (odds ratio (OR) 3.94; 95% confidence interval (CI): 1.51–10.25, p = 0.005) while there was a significantly reduced risk of HPV infection among those who used condoms (odds ratio (OR) 3.94; 95% confidence interval (CI): 0.18–0.91, p = 0.03). The HPV prevalence observed shows an increased transmission of the virus in Lagos, Nigeria. Therefore, there is a need for intense public awareness and the implementation of early detection tests, treatment, and vaccination to prevent an increase in cervical cancer cases in Lagos, Nigeria.

20 April 2020 in African Health Sciences
Verified
Journal Article
Open access
PDF file
OAOluwaseyi Sedowhe Ashaka
Oluwaseyi Sedowhe Ashaka
OSOlumuyiwa Babalola Salu
Olumuyiwa Babalola Salu
AJAyorinde Babatunde James
Ayorinde Babatunde James
AOAkeeb Oriowo Bola Oyefolu
Akeeb Oriowo Bola Oyefolu
AbdulAzeez A AnjorinAbdulAzeez A Anjorin
AbdulAzeez A Anjorin
SOSunday Aremu Omilabu
Sunday Aremu Omilabu
Background: Parvovirus B19 (B19) has tropism for cells of the erythroid lineage, which may lead to transient inhibition of erythropoiesis. Several studies and case reports suggested that B19 infection may contribute significantly to severe chronic ane- mia in HIV infected persons. Objective: To detect parvovirus B19 DNA in treatment-naïve HIV patients. Methods: This was a case control retrospective study. One hundred nineteen anemic and 81 non-anemic treatment-naïve HIV infected patients participated in the study at the Lagos University Teaching Hospital, Lagos, Nigeria. Polymerase chain reaction was used to detect B19 DNA. Results: Out of 200 patients analysed, 13(6.5%) had parvovirus B19 DNA. Eight HIV patients with anemia had B19 DNA while five non-anemic HIV patients had B19 DNA. This suggests that the presence of B19 DNA in the blood of HIV positive individuals may contribute to anemia because the majority (61.5%) who were positive for B19 DNA had anemia as compared to the non-anemic control group (38.5%). Conclusion: This study shows that the presence of B19 DNA in anemic HIV infected patients is not associated with chronic anaemia in HIV infection because no significant association exist. Keywords: Parvovirus B19; anemia; human immunodeficiency virus; polymerase chain reaction.

11 July 2020 in Current Medical Mycology
Verified
Journal Article
Open access
CEChimezie Ezenabike
Chimezie Ezenabike
OAOluwaseyi Sedowhe Ashaka
Oluwaseyi Sedowhe Ashaka
AOAdesuyi A. Omoare
Adesuyi A. Omoare
AFAbayomi Fadeyi
Abayomi Fadeyi
ASAlakija K. Salami
Alakija K. Salami
OAOlajide O. Agbede
Olajide O. Agbede
Background and Purpose: The potential for the invasion of the central nervous system by Cryptococcus species is underscored by the presence of this organism in the blood of immunocompromised individuals. Early adoption of sensitive methods for the diagnosis of Cryptococcus species will reduce the high morbidity and mortality associated with this disease. Regarding this, the aim of the present research was to detect cryptococcal antigen among HIV1- infected individuals in north-central Nigeria. Materials and Methods: This prospective cross-sectional study was carried out on HIV-1 infected individuals accessing care at three health facilities in north-central Nigeria between November 2014 and March 2017. For the purpose of the study, blood samples were collected from 300 HIV1-infected individuals within the age group of 3-65 years. The CD4+ T-cell count was determined, and the samples were analyzed for cryptococcal antigenemia using the methods of lateral flow assay (LFA) and culture technique. Results: Cryptococcus antigen was detected in 19.67% (59/300) of the patients, and only 25.4% (15/59) of the LFA-positive samples showed Cryptococcus species growth on Sabouraud dextrose agar after 3 days. Furthermore, fungal growth was observed in one of the specimens, which was LFA negative. Additionally, 30 of the 59 LFA-positive patients had cryptococcal antigen in their serum with a CD4+ T-cell count of < 150 cells/mm3. Conclusion: As the findings of the present study indicated, infection with Cryptococcus species is a problem among HIV-infected patients in the region under study. Therefore, all HIV patients, especially those with a CD4+ T-cell count of < 150 cells/mm3, referring to the HAART clinics in Nigeria, should be screened for cryptococcal antigen.

31 December 2024 in Babcock University Medical Journal
Verified
Journal Article
Open access
PDF file
OAOluwaseyi Sedowhe Ashaka
Oluwaseyi Sedowhe Ashaka
CEChinyere Ezeanya-Bakpa
Chinyere Ezeanya-Bakpa
FOFehintiola Olukoya
Fehintiola Olukoya
CACaleb Awodesu
Caleb Awodesu
OAOluwademilade Abdulkadir
Oluwademilade Abdulkadir
AOAbimbola Orukotan
Abimbola Orukotan
Objectives: This study determined the prevalence and risk implication of HBV and HCV in an asymptomatic university student group in Lagos, Nigeria. Methods: A total of 90 students (38 males and 52 females) aged 16-25 years were enrolled in this study. Hepatitis B surface Antigen (HBsAg) and Hepatitis C Virus Antibodies (Anti-HCV) were detected using an ELISA microplate spectrophotometer at 450nm absorbance. Data on medical and socio-demographic information was obtained using pretested structured self-administered questionnaires. Results: The overall seroprevalence for HBsAg and Anti-HCV was 2.2% respectively. Hepatitis B surface antigen was tested in 2 (5.3%) males only. Anti-HCV antibody was detected in both males and females with a prevalence of 1 (2.63%) and 1 (1.92%) respectively; with a male-to-female ratio of 1: 1. The age 19-21 years had HBsAg with a prevalence of 4.26%. The age group 16- 18 years and 19-21 years had an Anti-HCV prevalence of 3.57% and 2.12% respectively. Sexual intercourse, intravenous drug use, tattoos and body piercings were found to be associated (p < 0.05) with HBsAg and anti-HCV. Conclusions: The prevalence of HBV and HCV among undergraduate university students in Lagos was 2.2% respectively. HBsAg and anti-HCV were detected among an asymptomatic group of students aged 16 -21 years with associated risk factors. This group must be considered as a high-risk group for viral hepatitis infection intervention.

31 January 2018 in African Journal of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
OAOluwaseyi Sedowhe Ashaka
Oluwaseyi Sedowhe Ashaka
OAOlajide O. Agbede
Olajide O. Agbede
AOAdesuyi A. Omoare
Adesuyi A. Omoare
SESamuel K. Ernest
Samuel K. Ernest
Sera collected from 57 anaemic and 115 non-anaemic age-matched pre-school children in Ilorin, Nigeria, between November 2014 and December 2015 were assayed for human parvovirus B19-specific IgM antibodies by using the enzyme linked immunosorbent assay technique. A total of 17 (29.8%) anaemic children and 18 (15.7%) non-anaemic children were positive for parvovirus B19 infection. Infection with parvovirus B19 is common in this population, and screening for the virus during differential diagnosis is recommended.

1 January 2021 in Pan African Medical Journal
Verified
Journal Article
Open access
AbdulAzeez A AnjorinAbdulAzeez A Anjorin
AbdulAzeez A Anjorin
OAOluwaseyi Sedowhe Ashaka
Oluwaseyi Sedowhe Ashaka
STSodiq Olawale Tijani
Sodiq Olawale Tijani
JOJohn Oluwayomi Openibo
John Oluwayomi Openibo
IOIsmail Odetokun
Ismail Odetokun
There is an urgent need to properly understand the transmission dynamics of severe acute respiratory syndrome coronavirus 2 (SAR-CoV-2) in the event of continuous rise in morbidity in both humans and animals as well as an increase in the mortality rate in man. Since the novel SAR-CoV-2 emerged in Wuhan, China with its global spread in over 200 countries, several studies have been published on the epidemiology of the virus in man with limited information on the roles of animals and the possibility of reverse zoonosis. We, therefore, collected published research literature on COVID-19 from public search engines for information on SARS-CoV-2 in animals and reverse zoonosis from man. A critical and thorough study appraisal/evaluation was performed to include recent quality publications that focus on the scope of this write-up including zoonosis and reverse zoonosis of SARS-CoV-2. We highlighted what is known about SARS-CoV-2 in animals, identify gaps for future research, summarized possible reverse zoonotic transmission of SARS-CoV-2 from man to animals and included the likely implications of our summary for Africa, despite the dearth of information in Africa on the key concepts of this study.